The Technical Analyst
STRATA Skin Sciences, [SSKN]
Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Medical - Devices
STRATA Skin Sciences, Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.89% $0.540
/ 23 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 18.93 mill |
| EPS: | -0.310 |
| P/E: | -1.740 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 35.06 mill |
| Avg Daily Volume: | 0.0264 mill |
| RATING 2024-04-23 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.740 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -1.740 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.487 - 0.593 ( +/- 9.81%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-01 | Gov Shmuel | Buy | 4 800 | SSKN Common Stock |
| 2023-12-01 | Gov Shmuel | Buy | 300 | SSKN Common Stock |
| 2023-12-01 | Gov Shmuel | Buy | 562 | SSKN Common Stock |
| 2023-12-01 | Gov Shmuel | Buy | 14 338 | SSKN Common Stock |
| 2023-11-21 | Gov Shmuel | Buy | 416 250 | Employee Stock Option |
| INSIDER POWER |
|---|
| 94.91 |
| Last 91 transactions |
| Buy: 8 984 521 | Sell: 223 156 |
Forecast:
16:00 - $0.550
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.550
Forecast 2: 16:00 - $0.550
Forecast 3: 16:00 - $0.550
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.540 (1.89% ) |
| Volume | 0.0075 mill |
| Avg. Vol. | 0.0264 mill |
| % of Avg. Vol | 28.33 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SSKN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Last 10 Buy Signals
Latest Press Releases
2024-04-23 08:30:00 - Press Release
Strata Skin Sciences To Present At The Planet Microcap Showcase: Vegas 2024
Horsham, pa., april 23, 2024 (globe newswire) -- strata skin sciences, inc. (“strata” or the “company”) (nasdaq: sskn), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that dr. dolev rafaeli, president and chief executive officer, will present a corporate overview at the planet microcap showcase: vegas 2024. the conference is being held on april 30 – may 2, 2024 at the paris hotel & casino in las vegas.
2024-04-09 08:30:00 - Press Release
Strata Skin Sciences Announces Renewal Of Exclusive Distribution Agreements In China And Japan
Distributors in china and japan have each maintained exclusive distribution agreements with the company for over 10 years and collectively accounted for 46% of the company's total international revenue in 2023 distributors in china and japan have each maintained exclusive distribution agreements with the company for over 10 years and collectively accounted for 46% of the company's total international revenue in 2023
2024-03-27 16:01:00 - Press Release
Strata Skin Sciences Reports Fourth Quarter And Full-year 2023 Earnings
Company to host conference call and webcast today, march 27, 2024, at 4:30 pm et company to host conference call and webcast today, march 27, 2024, at 4:30 pm et
2024-03-13 08:00:00 - Press Release
Strata Skin Sciences To Report Fourth Quarter And Full-year 2023 Financial Results On March 27, 2024
Horsham, pa., march 13, 2024 (globe newswire) -- strata skin sciences, inc. (“strata” or the “company”) (nasdaq: sskn), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its fourth quarter and full-year 2023 financial results on wednesday, march 27, 2024. management will hold a conference call to review the financial results and provide a corporate update at 4:30 pm et on the same day.
2024-03-07 08:00:00 - Press Release
Strata Skin Sciences Announces Initiative To Expand Treatment Coverage
Horsham, pa., march 07, 2024 (globe newswire) -- strata skin sciences, inc. (“strata” or the “company”) (nasdaq: sskn), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an initiative aimed at expanding insurance coverage for essential treatments for conditions such as mycosis fungoides, lichen planus, alopecia areata, and cutaneous t-cell lymphoma (ctcl), with an initial targeted focus on expanding coverage for vitiligo and atopic dermatitis, skin diseases effecting up to 3 and 16 million people in the united states respectively1. the company is leveraging its extensive patient database and engaging in targeted governmental relations efforts, this initiative focuses on broadening current procedural terminology (“cpt”) code coverage to increase patient access to advanced treatments and enable higher provider reimbursement rates.
Latest News
2024-04-23 08:30:00 - GlobeNewsWire
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas.
2024-03-27 22:03:08 - Seeking Alpha
STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript
2024-03-13 08:00:00 - GlobeNewsWire
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
HORSHAM, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its fourth quarter and full-year 2023 financial results on Wednesday, March 27, 2024. Management will hold a conference call to review the financial results and provide a corporate update at 4:30 PM ET on the same day.
2023-12-01 08:00:00 - GlobeNewsWire
STRATA Skin Sciences to Participate in the Benchmark 12th Annual Discovery One-on-One Investor Conference
HORSHAM, Pa., Dec. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will be participating in the Benchmark 12th Annual Discovery One-on-One Investor Conference being held in New York City on December 7, 2023. Details for the event are as follows:
2023-11-14 21:24:09 - Seeking Alpha
STRATA Skin Sciences, Inc. (SSKN) Q3 2023 Earnings Call Transcript
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Rich Cockrell – Investor Relations Dolev Rafaeli – President and Chief Executive Officer Chris Lesovitz – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Ladenburg Thalmann Operator Greetings, and welcome to the STRATA Skin Sciences Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
2023-08-09 21:24:08 - Seeking Alpha
STRATA Skin Sciences, Inc. (SSKN) Q2 2023 Earnings Call Transcript
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Nicole Jones - IR Bob Moccia - CEO Chris Lesovitz - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Greetings. Welcome to STRATA Skin Sciences' 2Q 2023 Earnings Conference Call.
2023-07-28 08:00:00 - GlobeNewsWire
STRATA Skin Sciences to Report Second Quarter 2023 Financial Results on August 9, 2023
HORSHAM, Pa., July 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quarter 2023 financial results on Wednesday, August 9, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM ET on the same day.
2023-05-15 20:45:05 - Seeking Alpha
STRATA Skin Sciences, Inc. (SSKN) Q1 2023 Earnings Call Transcript
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Bob Moccia - Chief Executive Officer Chris Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. Welcome to the STRATA Skin Sciences First Quarter 2023 Earnings Conference Call.
2023-04-01 00:30:06 - Seeking Alpha
STRATA Skin Sciences, Inc. (SSKN) Q4 2022 Earnings Call Transcript
STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q4 2022 Earnings Conference Call March 31, 2023 8:30 AM ET Company Participants Bob Moccia - CEO Chris Lesovitz - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Hello, and welcome to the STRATA Skin Sciences Fourth Quarter 2022 and Full Year Earnings Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
2023-03-28 16:01:00 - GlobeNewsWire
STRATA Skin Sciences Reschedules Fourth Quarter 2022 Conference Call and Webcast to Friday, March 31, 2023
HORSHAM, Pa., March 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it will release its fourth quarter 2022 financial results along with its Form 10-K on Friday, March 31, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 8:30 AM EDT on the same day.